Brugmann university hospital
Brussels, 1020, Belgium
NCT Number: NCT05416892
The clinical pharmacists present in the hospitalisation units aim to ensure the daily review of the drug prescriptions of hospitalized patients.
In order to optimize their work, the objective of this study would be to provide them with a clinical decision support tool via artificial intelligence in order to improve the patient's medication management. This study will test the Pharmaclass® software.
Looking for future studies?
Notify Me75 year and older
All sexes
Observational
Brussels, 1020, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Clinical decision support tool via artificial intelligence in order to improve the patient's medication management.
Time frame: 5 months
Time required to perform an intervention (pharmacist versus software)
Time frame: 5 months
Dosage compliance with existing recommendations and laboratory results/clinical parameters (pharmacist versus software)
Time frame: 5 months
Severity of the medication error that could be avoided (pharmacist versus software)
Time frame: 5 months
Number of interventions validated/refused by the geriatrician (pharmacist versus software)
Murielle Surquin
Other
What is the Impact of Implementing Pharmaceutical Algorithms in the PharmaClass® Software, on the Handling the Patient's Medication Load, by the Clinical Pharmacist? Analysis of These Impacts Within 2 Geriatric Units of the CHU Brugmann Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06569290
Behavior, Diabetes
Boston, Massachusetts, United States
View Trial DetailsNCT05970471
Behavior, Breast Diseases
Besançon, France
View Trial DetailsNCT04410575
Anxiety Disorders, Behavior
Edmonton, Alberta, Canada
View Trial DetailsNCT06029842
Pharmacist-Patient Relations
Amman, Jordan
View Trial Details